Taking race into account when developing tools to predict a patient’s risk of colorectal cancer leads to more accurate predictions when compared with race-blind algorithms, researchers find.
After a 10-week summer program, twelve Johnson Summer Startup Accelerator (JSSA) student startups pitched their companies and shared their progress at Demo Day on Sept. 9 at the Sage Atrium in Ithaca, New York.
The award is the highest honor bestowed on students by SUNY and recognizes individuals who have demonstrated exceptional achievement across a range of areas, including academics, leadership and community service.
Jacob Anbinder, a Klarman postdoctoral fellow at Cornell University, researches how America’s most progressive cities become unaffordable for a significant portion of the population and the housing politics of prosperous metro areas. He says New York has a fundamental housing need: new homes now.
Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.
Nina Bassuk, emeritus professor and director of the Urban Horticulture Institute, and Alexander Kobald, associate director of the Design Across Scales Lab, comment on the growing global movement to plant more trees in cities.
For undergraduate would-be entrepreneurs, this competition encourages examining micro- or macro-level problems and envisioning ways to fix them via innovative business ventures.
Researchers at Weill Cornell Medicine have catalogued the cellular response to stroke in a preclinical model, identifying the immune cells involved and the roles they may play in the days and weeks following a stroke.
